BCYC Competitors & Alternatives
Compare Bicycle Therapeutics Ltd with similar stocks in the same industry
Biotechnology
BCYC
Main Stock$4.00
Tradestie Score
54
Market Cap
$577.32M
Revenue Growth
-0.9%
Analyst Upside
+215.6%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.08
|
$304.12M | - | 61 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.97
|
$297.23M | - | 50 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.59
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.48
|
$281.75M | 9.1 | 57 | Compare |
|
DBVT
DBV Technologies S.A.
|
$16.11
|
$275.54M | - | 54 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.07
|
$275.13M | - | 60 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.85
|
$269.08M | - | 56 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.43
|
$258.18M | - | 53 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.86
|
$256.54M | - | 61 | Compare |
More BCYC Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry